SCHEMBL14060397

SCHEMBL14060397

CC[C@]1(CC(=O)O)CCc2cc(-c3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3)ccc2C1=O

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14060396 1.00 DGAT1 (0.84) DGAT1
SCHEMBL14062349 1.00 DGAT1 (0.84) DGAT1
SCHEMBL14137118 0.91 DGAT1 (0.70) DGAT1
SCHEMBL14137125 0.90 DGAT1 (0.69) DGAT1
SCHEMBL14060208 0.90 DGAT1 (1.00) DGAT1
SCHEMBL17200562 0.90 DGAT1 (1.00) DGAT1
SCHEMBL14060257 0.89 DGAT1 (1.00) DGAT1
SCHEMBL17530454 0.89 DGAT1 (1.00) DGAT1
SCHEMBL14060253 0.89 DGAT1 (1.00) DGAT1
SCHEMBL14137090 0.89 DGAT1 (1.00) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723332-A1 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2014-04-30 — — EP disclosed
WO-2012162127-A1 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS GLAXOSMITHKLINE LLC (US) 2012-11-29 — — WO disclosed
Send feedback